FDA upgrades recall of eggs linked to salmonella to 'serious' health risks. Are there IN cases?
The recall was originally announced Sept. 6 by the Centers for Disease Control and Prevention. It was upgraded Sept. 30 to ...
Managed Healthcare Executive26m
FDA Approves Imuldose, the Fifth Stelara Biosimilar
Imuldose will be marketed in the United States by Accord BioPharma and is expected to launch in the first half of 2025.
FDA Approves IMULDOSA (ustekinumab-srlf), Accord BioPharma's Biosimilar to STELARA (ustekinumab), for the Treatment of Chronic Inflammatory Conditions
PRNewswire Ahmedabad Gujarat [India] October 14 Accord BioPharma Inc the US specialty division of Intas Pharmaceuticals Ltd ...
Bausch + Lomb Shares Rise on FDA Approval of enVista Envy Intraocular Lens
Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...
The Pharma Letter33m
FDA panel supports approval of Stealth’s elamipretide
Stealth BioTherapeutics received a favorable vote from an FDA advisory committee for elamipretide, aimed at treating Barth ...
Pharmaceutical Technology10m
Capricor touts long-term efficacy of DMD therapy ahead of FDA application
Capricor Therapeutics plans to apply for FDA approval for its DMD cell therapy, deramiocel, by the end of 2024.
ophthalmologytimes1h
FDA approves Bausch + Lomb’s enVista Envy range of IOLs
According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...
BioSpace9h
FDA Action Alert: Amgen, Camurus, Iterum and Lexicon
The FDA is looking at four events for the remainder of October, one of which is an advisory committee meeting for a dual SGLT ...
devdiscourse3h
FDA Greenlights IMULDOSA: A Game-Changer in Biosimilar Treatments
Accord BioPharma has received FDA approval for IMULDOSA, a biosimilar to STELARA, for treating chronic inflammatory conditions like psoriasis and Crohn's disease. Scheduled for a 2025 launch, it aims ...
Bausch + Lomb : FDA Approves EnVista Envy Full Range Of Vision Intraocular Lens
Bausch + Lomb Corp. (BLCO, BLCO.TO) announced that the U.S. Food and Drug Administration has approved the enVista Envy full range of ...
Food Safety News10h
FDA cracks down on food importers for major safety violations
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...